Although prostate cancer can be successfully treated in many men, when the disease develops bone metastases, it is eventually lethal. In a study published online in the journal Cancer Research, researchers show that the receptor CCR5, best known for its role…
Big Data to Make Big Difference in Childhood Cancer Treatment
University of Technology Sydney (UTS) research crunching vast amounts of data on childhood cancer to better tailor treatment is one step closer to assisting clinicians as the collaboration with the Kids Research Institute at The Children’s Hospital at Westmead celebrates 12…
New Ways to Drain Cancer’s identify by Researchers
Scientists at the University of Manchester have discovered a potential weakness in cancer’s ability to return or become resistant to treatment, by targeting the ‘fuel’ part of stem cells which allows tumors to grow. Cancer stem cells are particularly difficult to…
Improved Survival in Women with HER2 Negative Breast Cancer
The results from a pooled analysis of two Phase 3 Halaven (eribulin) trials are published in Breast Cancer Research and Treatment. Findings from the pooled analysis show that eribulin improves overall survival in women compared to control. This overall survival benefit…
Shutting Down Energy to Brain Cancer
A multicenter team of researchers has identified an enzyme key to the survival and spread of glioblastoma cancer cells that is not present in healthy brain cells, making the enzyme therapy a promising target. “With this enzyme, we may have found…
EBC 46 Human Trials Destroy Tumors
Scientists at QIMR Berghofer Medical Research Institute have used an experimental drug produced from the seeds of a rainforest plant to cure solid cancer tumors in preclinical trials. The study led by Dr. Glen Boyle at QIMR Berghofer’s Cancer Drug Mechanisms…
Paradigm Kicks Off Genomic Profiling for Cancer Registry
Paradigm has announced they have initiated genomic testing for Pharmatech’s AccessPPM Cancer Registry. Pharmatech’s AccessPPM is a cancer registry designed to collect EMR data and genomic information to help best match cancer patients with targeted clinical trials. The AccessPPM program and…
Multiple Strains for Clinical Development to be tested with Cannabis Science
Cannabis Science Inc. (OTC-QB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, announced that it has commenced production of multiple strains of cannabis and European Union certified hemp varieties to initiate scientific research to select the…